NCT00112697View on ClinicalTrials.gov

Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 6, 2003

Primary Completion Date

August 1, 2008

Study Completion Date

March 1, 2012

Conditions

Pancreatic Cancer

Interventions

DRUG

cisplatin

DRUG

docetaxel

DRUG

fluorouracil

RADIATION

radiation therapy

Trial Locations (10)

13273

Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes, Marseille

33310

Polyclinique des Quatre Pavillons, Lormont

34298

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier

44805

Centre Regional Rene Gauducheau, Nantes-Saint Herblain

49036

Centre Paul Papin, Angers

54511

Centre Alexis Vautrin, Vandœuvre-lès-Nancy

59020

Centre Oscar Lambret, Lille

69495

Centre Hospitalier Lyon Sud, Pierre-Bénite

92210

Centre Rene Huguenin, Saint-Cloud

F-94805

Institut Gustave Roussy, Villejuif

All Listed Sponsors

lead

UNICANCER

OTHER

NCT00112697 - Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter